Assertio Investor Relations Material
Latest events
Q1 2025
Assertio
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Assertio Holdings Inc
Access all reports
Segment Data
Access more data
Product sales by
Product
INDOCIN products
CAMBIA
Otrexup
SPRIX
Other
Expenses by
Financials
Assertio Holdings Inc. is a pharmaceutical company focused on the development, marketing, and distribution of prescription medications. The company specializes in providing treatments for patients with chronic pain, neurological disorders, and other medical conditions. Assertio's portfolio includes a range of therapies aimed at improving patient quality of life, with an emphasis on non-opioid options for pain management. The company is headquartered in Lake Forest, Illinois, and its shares are listed on the NASDAQ.
Latest articles
)
Upcoming IPOs to Watch in 2025
Potential IPOs in 2025 include prominent names like Shein, Databricks, Klarna, eToro, and Figma, to name a few. Let's take a closer look.
23 May 2025
)
Figma: Collaborative Design Tool Ready for IPO
Figma, the popular design platform, is preparing for a potential IPO in 2025 as it continues to reshape the future of collaborative design.
22 May 2025
)
Companies That Had Their IPO in 2024: Momentum Increasing
2024 marked a steady year for IPOs, driven by strong markets, AI momentum, and high-profile listings across industries and regions.
22 May 2025
Ticker symbol
ASRT
Country
🇺🇸 United States